Geert Maertens
Technik-/Wissenschafts-/F&E-Leiter bei Biocartis SA
Ursprung des Netzwerks ersten Grades von Geert Maertens
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Biocartis SA
 Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland.
23
| Subsidiary | Medical Specialties | 23 |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium.
14
| Subsidiary | Medical Specialties | 14 |
Ghent University
6
| College/University | Other Consumer Services | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Geert Maertens
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Public Communications Contact Corporate Officer/Principal | |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
| GALAPAGOS NV | Biotechnology | Director/Board Member Chairman Founder | |
| MDXHEALTH SA | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chairman | |
Novartis Seeds AG
 Novartis Seeds AG Chemicals: AgriculturalProcess Industries Part of Novartis AG, Novartis Seeds AG is a company that manufactures agro-chemical products. The company is based in Novartis, Switzerland. | Chemicals: Agricultural | Chief Tech/Sci/R&D Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
BARC SCS
 BARC SCS Miscellaneous Commercial ServicesCommercial Services BARC NV provides central laboratory services. It specializes in testing wide range of fields including virology, microbiology, clinical pathology, and genetics. The firm offers biobanking, cerba specimen, custom test development, data management, investigator support, project management, and logistics. The company is headquartered in Ghent, Belgium. | Miscellaneous Commercial Services | Founder Chief Executive Officer | |
Sopartec SA
 Sopartec SA Investment ManagersFinance Sopartec SA is the investment and technology valorization arm of Université Catholique de Louvain (UCL) and was founded in 1942. Sopartec SA is headquartered in Louvain-la-Neuve, Belgium. | Investment Managers | Private Equity Investor | |
deVGen NV
 deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member Director of Finance/CFO Director/Board Member | |
| ABLYNX | Biotechnology | Director of Finance/CFO Director/Board Member Director/Board Member Corporate Officer/Principal | |
| University of Utrecht | College/University | Doctorate Degree | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree Graduate Degree | |
| Vlerick Leuven Gent Management School | College/University | Corporate Officer/Principal Graduate Degree Masters Business Admin | |
Vlaams Instituut voor Biotechnologie - Flanders Institute
 Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | College/University | Director/Board Member Director/Board Member | |
MyCartis NV
 MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member | |
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
Capricorn Cleantech Fund NV
 Capricorn Cleantech Fund NV Investment ManagersFinance Capricorn Cleantech Fund NV makes early stage investments in technology start-ups that are based in Europe and that develop technologies with a reduced impact on water, air, soil and/or are active in the field of renewable energy. Target companies need to be privately held, and have substantial defendable intellectual property. Capricorn Cleantech acquires significant minority shareholdings. Initial investments vary between €1 to €5 million and also considers follow-on investments. Exits are made after a 3-7 year period, in some cases through an IPO. | Investment Managers | Director/Board Member | |
| Université Catholique de Louvain | College/University | Doctorate Degree Corporate Officer/Principal | |
Solvay Pharmaceuticals SA
 Solvay Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Solvay Pharmaceuticals SA develops, manufactures, and supplies pharmaceutical products. The company's products include cardio-metabolics, influenza vaccines, adjuvants, and women's and men's healthcare products. It offers fenofibrate, a cardio-metabolic product for treating raised blood lipids and dyslipidemia products that control cholesterol and triglycerides. The firm is headquartered in Brussels, France. | Pharmaceuticals: Major | Chief Executive Officer Public Communications Contact | |
reMYND NV
 reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
| CELYAD ONCOLOGY SA | Biotechnology | Chairman Corporate Officer/Principal | |
FlandersBio vzw
 FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman | |
| University of Antwerp | College/University | Doctorate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Corporate Officer/Principal | |
| Fujirebio US, Inc. | Founder Director of Finance/CFO | ||
Capricorn Venture Partners NV (Investment Management)
 Capricorn Venture Partners NV (Investment Management) Investment ManagersFinance Capricorn Venture Partners NV (Investment Management) (Capricorn Partners-IM) is the investment management division of Capricorn Venture Partners NV, a private venture company headquartered in Leuven, Belgium. The firm was founded in 1993 as a joint venture between Dr. Jos B. Peeters and Baring Venture Partners Ltd. They were renamed as Capricorn Venture Partners in 2019. Capricorn Partners-IM manages private and public equity investment funds for retail and institutional investors. | Investment Managers | Head-Equity Investments | |
Antabio SAS
 Antabio SAS Pharmaceuticals: MajorHealth Technology Antabio SAS operates as a biopharmaceutical company which develops drugs for the treatment and prevention of antibiotic-resistant bacterial infections. The firm focuses bacterial disease research, drug design, antibiotic combination testing, and in vitro technology development operations. The company was founded by Marc Lemonnier and Aymeric Dugray on October 15, 2009 and is headquartered in Labege, France. | Pharmaceuticals: Major | Director/Board Member | |
| BIOTALYS NV | Chemicals: Agricultural | Director/Board Member Director of Finance/CFO | |
| Harvard Business School | College/University | Masters Business Admin Undergraduate Degree | |
| BIOCARTIS GROUP NV | Medical Specialties | Director/Board Member Director/Board Member Chairman Chief Executive Officer Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Chief Operating Officer Director/Board Member | |
Confo Therapeutics NV
 Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Confo Therapeutics NV develops pharmaceutical products. It is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. The company was founded by Jan Steyaert and Toon Laeremans in June 2015 and is headquartered in Brussels, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
Horama SA
 Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Chairman | |
BrainVectis SAS
 BrainVectis SAS BiotechnologyHealth Technology BrainVectis SAS provides gene therapy services. It develops gene therapy treatments for neurodegenerative diseases by targeting the cholesterol pathway in the brain to restore cholesterol metabolism. The company was founded by Nathalie Cartier-Lacave and Jérôme Becquart in 2015 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
Inbiose NV
 Inbiose NV Pharmaceuticals: OtherHealth Technology Inbiose NV manufactures specialty carbohydrates. It offers carbohydrates, prebiotics, infant food formula, nutraceutical, human milk oligosaccharide, contract manufacturing, fermentation, Downstream processing, white biotechnology, monosaccharide, glycan, oligosaccharide, glyconutrients, bioactive. The company was founded in 2013 and is headquartered in Ghent, Belgium. | Pharmaceuticals: Other | Director of Finance/CFO | |
Aphea.Bio SA
 Aphea.Bio SA BiotechnologyHealth Technology Aphea.Bio SA engages in research and development of biotechnology and agricultural products. It develops next generation biopesticides and biostimulants based on natural microorganisms. The company was founded by Isabel Vercauteren and Steven Vandenabeele in December 5, 2016 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member | |
Paul Decraemer BV
 Paul Decraemer BV Miscellaneous Commercial ServicesCommercial Services Paul Decraemer BV provides business consulting services. The private company is based in Lochristi, Belgium. The CEO of the Belgian company is Paul Alfons Decraemer. | Miscellaneous Commercial Services | Chief Executive Officer | |
Syndesi Therapeutics SA
 Syndesi Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Syndesi Therapeutics SA develops novel therapeutics for cognitive impairment which includes Alzheimer’s disease, dementias, and cognitive impairment associated with schizophrenia. The company is headquartered in Louvain-la-Neuve, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Seelution AB
 Seelution AB Engineering & ConstructionIndustrial Services Seelution AB engages in emulsion technology coating solutions. Its products include renewable barriers, binders for stone wool and fiberglass insulation, release agents, anti-graffiti coating, wax emulsions for gypsum board, sizing agent for fibreboard, and toll manufacturing. The company was founded in and is headquartered in Hisings Backa, Sweden. | Engineering & Construction | Director/Board Member | |
| MINK THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Antelope Dx BV
 Antelope Dx BV Packaged SoftwareTechnology Services Antelope Dx BV develops a point-of-need diagnostics platform that provides patients, consumers, and healthcare professionals with on-the-spot access to key health parameters. The private company is based in Ghent, Belgium. The Belgian company was founded in 2019 by Jan-Willem Hoste and Hilde Windels. Hilde Windels has been the CEO since 2019. | Packaged Software | Director/Board Member Founder Director/Board Member | |
Pulsify Medical BV
 Pulsify Medical BV Medical SpecialtiesHealth Technology Pulsify Medical BV is a Belgian digital medical technology company that specializes in developing wearable ultrasound patches. The company is based in Louvain, Belgium. Pulsify Medical was founded in 2019 by Lieven Herbots, Xavier Rottenberg, Jan D'hooge, Steve Stoffels. Iwan van Vijfeijken has been the CEO of the company since 2019. | Medical Specialties | Director/Board Member | |
| PHAXIAM THERAPEUTICS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| 7C SOLARPARKEN AG | Electric Utilities | Director/Board Member |
Statistik
International
| Belgien | 33 |
| Frankreich | 6 |
| Vereinigte Staaten | 5 |
| Vereinigtes Königreich | 3 |
| Schweiz | 3 |
Sektoral
| Health Technology | 25 |
| Consumer Services | 8 |
| Commercial Services | 7 |
| Finance | 6 |
| Process Industries | 4 |
Operativ
| Director/Board Member | 236 |
| Corporate Officer/Principal | 80 |
| Independent Dir/Board Member | 47 |
| Chairman | 46 |
| Chief Executive Officer | 46 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Raj Bhikhu Parekh | 50 |
| Rudi Mariën | 31 |
| Philippe Archinard | 24 |
| Staf van Reet | 22 |
| Frank Morich | 21 |
| Rudi Pauwels | 19 |
| Ruth Devenyns | 18 |
| Werner Cautreels | 18 |
| Hilde Windels | 18 |
| Françoise Roels | 17 |
| Domenico Valerio | 15 |
| Philip Julien de Cnudde | 14 |
| Peter Piot | 14 |
| Paul Alfons Decraemer | 13 |
| Thomas Wayne Gibbs | 11 |
- Börse
- Insiders
- Geert Maertens
- Unternehmensverbindungen